Friday, January 06, 2023 10:31:27 PM
Cost Bil s to bring a drug to market , it’s incredible that a small bio co to get to this point !!!! The P3 is a success and FDA approval appears to be forthcoming, With less than 200 Mil they had to raise more , I was not surprised they pulled trigger to secure funds , Was a little disappointed in 2.45 per share would liked to see 3-4 bucks
I think a reverse split is a year or so down road , hope so , the co s that just purchase 200 mil wouldn’t accept it & sure a provision in deal making sure it won’t happen until after their out
Listen , securing funds is just smart , there is NO Company if they didn’t secure funds - showing big Pharm they are in good financial position is very important. In fact it attracts interest & offers. Think about it , with out money ?? in the bank their nothing more than a Co with a valuable asset that will forced to sell or be overrun by competitors with money & their asset
In the real world this is how it works so put on big boys pants watch & learn
JMHO
I think a reverse split is a year or so down road , hope so , the co s that just purchase 200 mil wouldn’t accept it & sure a provision in deal making sure it won’t happen until after their out
Listen , securing funds is just smart , there is NO Company if they didn’t secure funds - showing big Pharm they are in good financial position is very important. In fact it attracts interest & offers. Think about it , with out money ?? in the bank their nothing more than a Co with a valuable asset that will forced to sell or be overrun by competitors with money & their asset
In the real world this is how it works so put on big boys pants watch & learn
JMHO
Recent GERN News
- Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/01/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 08:01:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:45:05 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/18/2026 08:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:40:51 PM
- First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 • GlobeNewswire Inc. • 05/12/2026 01:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:49:33 PM
- Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Geron Plans to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/05/2026 12:00:00 PM
- Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 12:14:14 AM
- Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/14/2026 08:05:00 PM
- Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary • GlobeNewswire Inc. • 04/13/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 08:31:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 08:30:34 PM
- Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:30:20 PM
